Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Obsidian Therapeutics, Inc.

Clinical trials sponsored by Obsidian Therapeutics, Inc., explained in plain language.

Obsidian Therapeutics, Inc. OBX NASDAQ

A clinical-stage biotech developing engineered cell therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

Immune cells supercharged to fight advanced cancers

Disease control Recruiting now

This study tests an experimental treatment called OBX-115 for people with advanced melanoma or non-small cell lung cancer that has spread or stopped responding to standard therapy. OBX-115 uses a patient's own immune cells (tumor-infiltrating lymphocytes) that are modified in the…

Phase: PHASE1, PHASE2 • Sponsor: Obsidian Therapeutics, Inc. • Aim: Disease control

Last updated Jul 18, 2026 00:00 UTC